Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.15, Iss.2, 2005-02, pp. : 237-241
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Arylsulphonamide hydroxamic acids as potent inhibitors of MMP-13
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. :
Novel cyclic N-hydroxamic acid inhibitors of TNF- synthesis and MMP-13
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. :
Cyclic sulphone MMP inhibitors
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. :
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. :